Breast surgical oncologist Mediget Teshome was named chief of breast surgery and director of breast health at UCLA Health.
Jennifer Gillette was named the University of New Mexico Comprehensive Cancer Center’s associate director for training and education.
The University of Cincinnati Cancer Center’s Maria F. Czyzyk-Krzeska was awarded a five-year, $2.8 million grant from the NIH to investigate how copper contributes to the advancement and recurrence of the most common type of kidney cancer, clear cell renal cell carcinoma.
Jezabel Rodriguez Blanco, who has a dual appointment at MUSC Hollings Cancer Center and the Darby Children’s Research Institute at MUSC, will receive $800,000 over four years from Alex’s Lemonade Stand Foundation for Childhood Cancer to continue her pursuit of the causes of medulloblastoma relapse.
St. Jude Children’s Research Hospital invested nearly $13 million toward a research collaboration with scientists at Columbia University, Duke University, and Stanford University to expand the understanding of G-protein coupled receptors, which are vital proteins that impact human health and disease.
The Centers for Medicare & Medicaid Services issued its rule requiring federal health plans—including Medicare Advantage plans, Medicaid plans, and Qualified Health Plans on Federally Facilitated Exchanges—to establish an electronic prior authorization process that will be integrated into providers’ workflows.
The National Association for Proton Therapy commended CMS for ensuring seniors have timely access to medical care, especially advanced cancer treatments, through the Advancing Interoperability and Improving Prior Authorization Processes, or e-PA, Rule.
Roy S. Herbst, deputy director of Yale Cancer Center and Smilow Cancer Hospital and assistant dean for translational research at Yale School of Medicine, was elected to the Friends of Cancer Research Board of Directors.
Mohandas Narla, head of the laboratory of red cell physiology at New York Blood Center Enterprises, began his term as president of the American Society of Hematology. He will serve a year-long term through December 2024.
The largest professional societies representing radiation oncology physicians in the United States announced a partnership with the goal of reforming radiation oncology Medicare payments to expand and enhance access to high quality care for people with cancer.